Larynx Comp.
Arzneimittel · European Medicines Agency · Deutschland
Was die Quelle veröffentlicht
- Zulassungsinhaber
- Wala Heilmittel Gmbh
- Wirkstoffe
- Levisticum Officinale E Radice Ferm 33c Dil. D5 (Hab, Vs. 33c), Larynx Bovis Gl Dil. D5 (Hab, Vs. 41b), Nervus Laryngeus Recurrens Bovis Gl Dil. D5 (Hab, Vs. 41a), Nervus Laryngeus Superior Bovis Gl Dil. D5 (Hab, Vs. 41a), Nervus Vagus Bovis Gl Dil. D5 (Hab, Vs. 41a)
- Verabreichungswege
- Subcutaneous Use
- Administrativer Status
- listed-as-authorised
Namen, unter denen dieser Datensatz gefunden wird
- Larynx Comp.
- Levisticum Officinale E Radice Ferm 33c Dil. D5 (Hab, Vs. 33c), Larynx Bovis Gl Dil. D5 (Hab, Vs. 41b), Nervus Laryngeus Recurrens Bovis Gl Dil. D5 (Hab, Vs. 41a), Nervus Laryngeus Superior Bovis Gl Dil. D5 (Hab, Vs. 41a), Nervus Vagus Bovis Gl Dil. D5 (Hab, Vs. 41a)
Vollständige Quelldaten
{
"name": "Larynx Comp.",
"holder": "Wala Heilmittel Gmbh",
"routes": [
"Subcutaneous Use"
],
"marketed": null,
"useDomain": "unknown",
"databaseDate": "2026-10-09",
"sourceStatus": null,
"supplyRegime": null,
"listingStatus": "listed-as-authorised",
"targetSpecies": [],
"sourceRowCount": 1,
"activeSubstances": [
"Levisticum Officinale E Radice Ferm 33c Dil. D5 (Hab, Vs. 33c), Larynx Bovis Gl Dil. D5 (Hab, Vs. 41b), Nervus Laryngeus Recurrens Bovis Gl Dil. D5 (Hab, Vs. 41a), Nervus Laryngeus Superior Bovis Gl Dil. D5 (Hab, Vs. 41a), Nervus Vagus Bovis Gl Dil. D5 (Hab, Vs. 41a)"
],
"documentRevision": "90",
"documentReference": "EMA/518502/2018",
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "de.ema.article57"
},
"patientEligibility": "not-assessed",
"centrallyAuthorised": false,
"targetSpeciesStatus": "not-reported",
"activeSubstancesText": "Levisticum Officinale E Radice Ferm 33c Dil. D5 (Hab, Vs. 33c), Larynx Bovis Gl Dil. D5 (Hab, Vs. 41b), Nervus Laryngeus Recurrens Bovis Gl Dil. D5 (Hab, Vs. 41a), Nervus Laryngeus Superior Bovis Gl Dil. D5 (Hab, Vs. 41a), Nervus Vagus Bovis Gl Dil. D5 (Hab, Vs. 41a)",
"administrativeStatus": "unknown",
"prescriptionCategory": "unknown",
"prescriptionRequired": null,
"authorisationTerritory": "Germany",
"pharmacovigilanceContacts": [
{
"email": "arzneimittelsicherheit@wala.de",
"phone": "+49 (0) 7164 930-4444",
"masterFileLocation": "Germany"
}
]
}
Diesen Datensatz aus Ihrer eigenen Software abrufen
Derselbe Datensatz, mit allen Feldern und seiner Herkunft, ist nur eine Anfrage entfernt. Ein API-Schlüssel ist kostenlos und funktioniert sofort.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=de" \
--data-urlencode "sourceId=de.ema.article57" \
--data-urlencode "id=de:ema:article57:8ebc5db7ef58350cef45"